- Report
- April 2026
- 145 Pages
Global
From €2689EUR$2,999USD£2,298GBP
€3586EUR$3,999USD£3,064GBP
- Report
- September 2025
- 280 Pages
Global
From €4479EUR$4,995USD£3,827GBP
- Report
- May 2026
- 152 Pages
Global
From €3542EUR$3,950USD£3,026GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- November 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- September 2025
- 150 Pages
Global
From €4349EUR$4,850USD£3,716GBP
- Report
- March 2026
- 84 Pages
Global
From €3500EUR$4,182USD£3,095GBP
- Report
- January 2026
- 82 Pages
Global
From €3500EUR$4,182USD£3,095GBP
- Report
- August 2025
- 90 Pages
United States
From €2286EUR$2,550USD£1,954GBP
- Report
- August 2026
Global
From €750EUR$896USD£663GBP
- Report
- November 2024
- 600 Pages
Global
From €2959EUR$3,300USD£2,528GBP
- Report
- July 2020
- 1200 Pages
Japan
From €2690EUR$3,000USD£2,298GBP
- Clinical Trials
- February 2018
- 225 Pages
Global
From €2152EUR$2,400USD£1,839GBP
- Report
- August 2025
- 200 Pages
Canada
From €2233EUR$2,490USD£1,908GBP
- Report
- July 2025
- 80 Pages
United States
From €5335EUR$5,950USD£4,558GBP
- Report
- August 2025
- 189 Pages
Global
From €3179EUR$3,545USD£2,716GBP
€3532EUR$3,939USD£3,018GBP
- Report
- August 2025
- 187 Pages
Global
From €3179EUR$3,545USD£2,716GBP
€3532EUR$3,939USD£3,018GBP
- Report
- February 2025
Global
From €4393EUR$4,900USD£3,754GBP
- Report
- August 2025
- 181 Pages
Global
From €3179EUR$3,545USD£2,716GBP
€3532EUR$3,939USD£3,018GBP

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient.
The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more